Cinryze is a Intravenous Injection, Powder, Lyophilized, For Solution in the Plasma Derivative category. It is labeled and distributed by Viropharma Biologics Llc. The primary component is Human C1-esterase Inhibitor.
Product ID | 42227-081_0fb47377-d040-43b5-8502-f788c67c06aa |
NDC | 42227-081 |
Product Type | Plasma Derivative |
Proprietary Name | Cinryze |
Generic Name | Human C1-esterase Inhibitor |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2008-12-01 |
Marketing Category | BLA / BLA |
Application Number | BLA125267 |
Labeler Name | ViroPharma Biologics LLC |
Substance Name | HUMAN C1-ESTERASE INHIBITOR |
Active Ingredient Strength | 500 [iU]/5mL |
Pharm Classes | Decreased Vascular Permeability [PE], Human C1 Esterase Inhibitor [EPC], Kallikrein Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2008-12-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125267 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | EA |
Marketing Start Date | 2017-01-19 |
Marketing Category | BLA |
Application Number | BLA125267 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | EA |
Marketing Start Date | 2008-12-01 |
Ingredient | Strength |
---|---|
HUMAN C1-ESTERASE INHIBITOR | 500 [iU]/5mL |
NDC | Brand Name | Generic Name |
---|---|---|
42227-081 | Cinryze | HUMAN C1-ESTERASE INHIBITOR |
42227-083 | Cinryze | HUMAN C1-ESTERASE INHIBITOR |
63833-825 | Berinert | HUMAN C1-ESTERASE INHIBITOR |
63833-828 | HAEGARDA | HUMAN C1-ESTERASE INHIBITOR |
63833-829 | HAEGARDA | HUMAN C1-ESTERASE INHIBITOR |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CINRYZE 86743947 not registered Dead/Abandoned |
ViroPharma Biologics, Inc. 2015-09-01 |
CINRYZE 77644301 3654422 Live/Registered |
VIROPHARMA BIOLOGICS, INC. 2009-01-06 |
CINRYZE 77212428 3867834 Live/Registered |
VIROPHARMA BIOLOGICS, INC. 2007-06-21 |